Cystic Fibrosis Remote Monitoring System
Primary Purpose
Cystic Fibrosis
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
InCourage-Connect
InCourage
Sponsored by
About this trial
This is an interventional supportive care trial for Cystic Fibrosis
Eligibility Criteria
Inclusion Criteria:
- Have a diagnosis of cystic fibrosis
- Be physically capable of and willing to use the study device
- Access to an internet connection
- Access to a mobile device capable of using applications
- Be familiar with how to utilize a mobile device and/or applications
- Self-reported CF-related therapy adherence between 25%-75% on a screening questionnaire
Exclusion Criteria:
- History of solid-organ transplant
- Inability to speak and read the English language
- Any contraindication to vest use for airway clearance
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Interactive coaching
Standard of care coaching
Arm Description
Airway clearance therapy using goal setting and interactive feedback.
Standard of care airway clearance therapy.
Outcomes
Primary Outcome Measures
Airway Clearance Therapy Adherence
Intervention comparison of adherence measurements: a) to prescribed pressure based upon % of time at prescribed pressure and b) to prescribed duration of treatment based upon % of time using the airway clearance device at prescribed duration (weekly capture).
Secondary Outcome Measures
Lung Function
Intervention comparison of pre and post measures of FEV1 and FVC.
Quality of Life Measurement
Intervention comparison based upon pre and post Cystic Fibrosis Questionnaire Revised (CFQ-R).
Name of categories/domains CFQ-R:
9 Quality of life domains: Physical, role/school, vitality, emotion, social, body image, eating, treatment burden, health perceptions.
3 symptom scales: Weight, respiratory, and digestion.
Scaling of items:
5 distinct 4-point Likert scales (e.g., always/often/ sometime/never)
Scoring:
Scores for each domain; after recording, each item is summed to generate a domain score and standardized. Scores range from 0 to 100, with higher scores indicating better health.
CF Respiratory Symptoms
Intervention comparison based upon pre and post CF Respiratory Symptom Score (CRSS) assessment.
The score evaluates four symptoms: cough, sputum, breathlessness and fatigue. Each symptom is scored from one (mild symptoms) to four (severe symptoms). The total symptom score was the summation of all the four symptoms.
Scores range from 4 to 16 with 4 being mild to 16 being most severe.
Full Information
NCT ID
NCT04453358
First Posted
June 24, 2020
Last Updated
June 30, 2020
Sponsor
Koronis Biomedical Technologies
Collaborators
Johns Hopkins University
1. Study Identification
Unique Protocol Identification Number
NCT04453358
Brief Title
Cystic Fibrosis Remote Monitoring System
Official Title
Cystic Fibrosis Remote Monitoring System to Support Resource-Limited Communities
Study Type
Interventional
2. Study Status
Record Verification Date
June 2020
Overall Recruitment Status
Unknown status
Study Start Date
September 1, 2020 (Anticipated)
Primary Completion Date
July 31, 2021 (Anticipated)
Study Completion Date
August 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Koronis Biomedical Technologies
Collaborators
Johns Hopkins University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The objective of this study is to determine if interactive technology (i.e. virtual coaching) that facilitates vest therapy goal setting and provides positive reinforcement will increase adherence to vest therapy for airway clearance in individuals with CF.
Detailed Description
Cystic fibrosis (CF) is a life-limiting multi-system disease primarily characterized by chronic lung infections and pulmonary symptoms such as cough, dyspnea, and chest tightness. Those with CF rely on numerous pharmaceutical and treatment-based therapies as part of their routine care to maintain lung health. Airway clearance, one such treatment-based therapy, uses breathing techniques and various vibrating devices to mobilize lung secretions and is considered a cornerstone of CF care. Vest therapy, a "shaking vest" that applies pressure and high frequency vibrations to the chest wall is the most commonly used technique for airway clearance in the U.S., but adherence to recommended goals for airway clearance is low. Barriers to adherence include the time limitations and unclear goal setting for effective treatment. A previous pilot study by this research team showed that CF patients find the use of airway clearance vests equipped with both pre-set and individually determined programing capabilities as well as electronic monitoring and transmitting capabilities to be acceptable and feasible. Information such as vest-use time, vest pressure measures, programming choices and symptom reporting is captured by these devices and transmitted to health care teams for review as well as provided to patients to provide feedback on treatment goals. This study aims to determine if providing patients with clearly stated treatment goals and the means to monitor and receive positive reinforcing feedback on vest use through interactive technology (i.e. virtual coaching) will improve vest therapy adherence in individuals with CF.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study is a randomized-comparative study investigating the effectiveness of either low-level virtual coaching vs. high-level virtual coaching in improving airway clearance treatment adherence.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
35 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Interactive coaching
Arm Type
Active Comparator
Arm Description
Airway clearance therapy using goal setting and interactive feedback.
Arm Title
Standard of care coaching
Arm Type
Active Comparator
Arm Description
Standard of care airway clearance therapy.
Intervention Type
Device
Intervention Name(s)
InCourage-Connect
Intervention Description
This intervention will provide patients with clearly stated treatment goals and provide them with interactive feedback based on usage date to help support airway clearance therapy adherence.
Intervention Type
Device
Intervention Name(s)
InCourage
Intervention Description
This intervention will provide standard of care airway clearance therapy with no interactive feedback on treatment goals and usage.
Primary Outcome Measure Information:
Title
Airway Clearance Therapy Adherence
Description
Intervention comparison of adherence measurements: a) to prescribed pressure based upon % of time at prescribed pressure and b) to prescribed duration of treatment based upon % of time using the airway clearance device at prescribed duration (weekly capture).
Time Frame
90 days
Secondary Outcome Measure Information:
Title
Lung Function
Description
Intervention comparison of pre and post measures of FEV1 and FVC.
Time Frame
180 days
Title
Quality of Life Measurement
Description
Intervention comparison based upon pre and post Cystic Fibrosis Questionnaire Revised (CFQ-R).
Name of categories/domains CFQ-R:
9 Quality of life domains: Physical, role/school, vitality, emotion, social, body image, eating, treatment burden, health perceptions.
3 symptom scales: Weight, respiratory, and digestion.
Scaling of items:
5 distinct 4-point Likert scales (e.g., always/often/ sometime/never)
Scoring:
Scores for each domain; after recording, each item is summed to generate a domain score and standardized. Scores range from 0 to 100, with higher scores indicating better health.
Time Frame
180 days
Title
CF Respiratory Symptoms
Description
Intervention comparison based upon pre and post CF Respiratory Symptom Score (CRSS) assessment.
The score evaluates four symptoms: cough, sputum, breathlessness and fatigue. Each symptom is scored from one (mild symptoms) to four (severe symptoms). The total symptom score was the summation of all the four symptoms.
Scores range from 4 to 16 with 4 being mild to 16 being most severe.
Time Frame
180 days
10. Eligibility
Sex
All
Minimum Age & Unit of Time
14 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Have a diagnosis of cystic fibrosis
Be physically capable of and willing to use the study device
Access to an internet connection
Access to a mobile device capable of using applications
Be familiar with how to utilize a mobile device and/or applications
Self-reported CF-related therapy adherence between 25%-75% on a screening questionnaire
Exclusion Criteria:
History of solid-organ transplant
Inability to speak and read the English language
Any contraindication to vest use for airway clearance
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Noah Lechtzin, MD
Phone
(410) 502-7044
Email
nlechtz1@jhmi.edu
First Name & Middle Initial & Last Name or Official Title & Degree
Patrick Lichter
Phone
6127301091
Email
plichter@koronisbiotech.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Noah Lechtzin, MD
Organizational Affiliation
Johns Hopkins University
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Cystic Fibrosis Remote Monitoring System
We'll reach out to this number within 24 hrs